Come up with a name for your new list and we'll add to it:
Oncternal Therapeutics raised a round of funding on August 07, 2015. Investors include
Hale BioPharma Ventures.
Oncternal Therapeutics, formerly Tokalas, is a clinical-stage oncology company developing first-in-class and novel therapies for both rare and common cancers by focusing on targets that are uniquely e…